AMRX News and Press, Amneal Pharmaceuticals Inc. Class A From 07/29/19

Alkermes plc ( ALKS +2.9% ) inks an agreement with Amneal Pharmaceuticals LLC ( AMRX +1.6% ) settling the latter's challenge to a U.S. patent covering opioid/alcohol dependence med VIVITROL (naltrexone for extended-release injectable suspension) that expires in 2029. More news on: Al...

Peak Resorts (NASDAQ: SKIS ) +113%  on being acquired by Vail Resorts. More news on: Peak Resorts, Inc., Condor Hospitality Trust, Inc., BioXcel Therapeutics, Inc., Stocks on the move, Read more ...

Amneal Pharmaceuticals (NYSE: AMRX ) is up  6%  premarket after the launch of its generic version of Pfizer's Lyrica (pregabalin capsules) 25 mg, 50, 75, 100, 150, 200, 225 and 300 mg. More news on: Amneal Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, ...

Bridgebio Pharma (NASDAQ: BBIO ) initiated with Buy rating and $42 (53% upside) price target at Goldman Sachs. Initiated with Buy rating and $38 price target at Jefferies. Initiated with Outperform rating and $49 price target at BMO. Initiated with Outperform rating and $34 price target at S...

- Company has launched 21 generic products so far in 2019 - Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has received approval for, and launched, its generic version of Lyrica ® (pregabalin capsules) 25 mg, 50 mg, 75, mg, 100 mg, 150 mg, 200 mg, 225 mg a...

July 18, 2019 Palm Beach, FL –July 18, 2019 – Acute myeloid leukemia (AML) is a cancer that is rarely seen before age 45 with the average age of onset around 65. It is the most common of the four major types of leukemia. Without treatment, AML is often deadly wi...

Insider buying is usually a bullish sign while insider selling is seen as bearish. For instance, there were a lot of executive options exercised with some of them sold at $13.44 on May 7th on Amneal Pharmaceuticals, Inc. ( AMRX ) a couple of days before the company was to release Q1 results: ...

Spectrum Pharmaceuticals (NASDAQ: SPPI ) initiated with Buy rating and $18 (114% upside) price target at B. Riley FBR. More news on: Spectrum Pharmaceuticals, Inc., Immunic, Inc., Amneal Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Gainers:  Vislink Technologies (NASDAQ: VISL ) +316% . Attis Industries (NASDAQ: ATIS ) +32% . Valeritas Holdings (NASDAQ: VLRX ) +27% . Harmonic (NASDAQ: HLIT ) +26% . Akoustis Technologies (NASDAQ: AKTS ) +21% . SMART Global Holdings (NASDAQ: SGH ) +21% . ContraVir Pharmaceuti...

Camber Energy (NYSEMKT: CEI ) -21% . More news on: Camber Energy, Inc., Amneal Pharmaceuticals, Inc., Yuma Energy, Inc., Stocks on the move, Read more ...